专家洞见

GLG的专家团拥有约 100 万名成员，涵盖所有主要行业与地区的意见领袖。
在此可浏览部分专家的观点。

按洞见类型 全部
全部文章案例研究视频白皮书播客
The State of Pharma Contract Development and Manufacturing Organizations
文章

The State of Pharma Contract Development and Manufacturing Organizations

CDMO, Pharmaceutical Industry, Healthcare and Life Sciences
What We Can Do about Wasted Pharmaceuticals
文章

What We Can Do about Wasted Pharmaceuticals

Pharmaceutical Industry, Healthcare and Life Sciences
Challenges and Opportunities in Australia’s Radiology Industry
文章

Challenges and Opportunities in Australia’s Radiology Industry

Radiology, Healthcare and Life Sciences
The Inflation Reduction Act: What Drugmakers Should Know
文章

The Inflation Reduction Act: What Drugmakers Should Know

Pharmaceutical Industry, Global Politics, Healthcare and Life Sciences
Looking at the Australian National Disability Insurance Scheme (NDIS)
文章

Looking at the Australian National Disability Insurance Scheme (NDIS)

Australia, Healthcare and Life Sciences
At-Home Healthcare After COVID-19
文章

At-Home Healthcare After COVID-19

Coronavirus, Healthcare and Life Sciences
TPP Testing in Pharma: Best Practices
文章

TPP Testing in Pharma: Best Practices

Pharmaceutical Industry, TPP, Healthcare and Life Sciences
Drilling into Dental Industry Trends
文章

Drilling into Dental Industry Trends

Coronavirus, Dental Services, Dentists, Healthcare and Life Sciences
Radiation Oncology Market: The Battle for Doctors
文章

Radiation Oncology Market: The Battle for Doctors

Oncology, Radiology, Healthcare and Life Sciences
GLG Institute’s “Effective Leadership Development in a Post-COVID World” roundtable highlights
文章

GLG Institute’s “Effective Leadership Development in a Post-COVID World” roundtable highlights

Coronavirus, Leadership, Healthcare and Life Sciences
Analyzing Australia’s Response to COVID-19
文章

Analyzing Australia’s Response to COVID-19

Australia, Coronavirus, Global Politics, Healthcare and Life Sciences
Report: Illuminating Invisible Inequities in Healthcare
文章

Report: Illuminating Invisible Inequities in Healthcare

Healthcare and Life Sciences, Social Impact
Biogen’s Aduhelm: An Update on the Commercial Rollout
文章

Biogen’s Aduhelm: An Update on the Commercial Rollout

Alzheimer’s, Biogen, Pharmaceutical Industry, Healthcare and Life Sciences
FDA’s Controversial Aduhelm Approval: What Happens Next?
文章

FDA’s Controversial Aduhelm Approval: What Happens Next?

Alzheimer’s, Biogen, Pharmaceutical Industry, Healthcare and Life Sciences
The Future of Healthcare in India
文章

The Future of Healthcare in India

India, Telemedicine, Healthcare and Life Sciences
Professor Lawrence Gostin on Mask and Vaccine Mandates
文章

Professor Lawrence Gostin on Mask and Vaccine Mandates

Coronavirus, Healthcare and Life Sciences
Why the FDA Was Correct in Approving Biogen’s Aducanumab
文章

Why the FDA Was Correct in Approving Biogen’s Aducanumab

Alzheimer’s, Health Care, Healthcare and Life Sciences
Insights from GLG Institute’s 2021 Healthcare Leadership Summit
文章

Insights from GLG Institute’s 2021 Healthcare Leadership Summit

Boardroom, Corporate Responsibility, Innovation, Leadership, Healthcare and Life Sciences
Jeb Bush and Martin O’Malley on Reopening After COVID-19
文章

Jeb Bush and Martin O’Malley on Reopening After COVID-19

Policy, U.S. Politics, Global Politics, Healthcare and Life Sciences
COVID Vaccinations in Hong Kong: An Update
文章

COVID Vaccinations in Hong Kong: An Update

Coronavirus, Vaccines, Healthcare and Life Sciences
COVID Vaccinations in Hong Kong: Q and A
文章

COVID Vaccinations in Hong Kong: Q and A

Coronavirus, Vaccines, Healthcare and Life Sciences
Biden’s Healthcare Priorities
文章

Biden’s Healthcare Priorities

Biden, Coronavirus, U.S. Politics, Vaccines, Global Politics, Healthcare and Life Sciences
Updates on COVID-19: New Variants and Vaccination Campaigns
文章

Updates on COVID-19: New Variants and Vaccination Campaigns

Coronavirus, Vaccines, Healthcare and Life Sciences
An Overview of Southeast Asian Healthcare Delivery
文章

An Overview of Southeast Asian Healthcare Delivery

HMO, Primary Care, Healthcare and Life Sciences
Obamacare Likely to Be Safe from Supreme Court, Kathleen Sebelius Says
文章

Obamacare Likely to Be Safe from Supreme Court, Kathleen Sebelius Says

Affordable Care Act, Obamacare, Supreme Court., Healthcare and Life Sciences
Kathleen Sebelius: ‘Trickle-Down Chaos’ Led to Poor COVID Response
文章

Kathleen Sebelius: ‘Trickle-Down Chaos’ Led to Poor COVID Response

Coronavirus, Vaccines, Healthcare and Life Sciences
The Future of Digital Health in India
文章

The Future of Digital Health in India

Coronavirus, Healthcare and Life Sciences
Healthcare Leadership: 3 Takeaways from 2020
文章

Healthcare Leadership: 3 Takeaways from 2020

industry insights, Healthcare and Life Sciences
Covid-19 Vaccines and Therapeutics: Where We Stand Now
文章

Covid-19 Vaccines and Therapeutics: Where We Stand Now

Coronavirus, Therapeutics, Vaccines, Healthcare and Life Sciences
Is Asian Healthcare on the Verge of a Digital Revolution?
文章

Is Asian Healthcare on the Verge of a Digital Revolution?

Technology, Telemedicine, Healthcare and Life Sciences
J.P. Morgan Healthcare 2021: How to Make the Most of This Year’s Virtual Conference
文章

J.P. Morgan Healthcare 2021: How to Make the Most of This Year’s Virtual Conference

Conferences, J.P. Morgan, Healthcare and Life Sciences
The 2021 Physician Staffing Outlook
文章

The 2021 Physician Staffing Outlook

Coronavirus, Physicians, Staffing, Healthcare and Life Sciences
The Nutraceuticals Market Is Booming. Will It Last?
文章

The Nutraceuticals Market Is Booming. Will It Last?

Consumer Packaged Goods, Nutraceuticals, Healthcare and Life Sciences
Ebook: The Rise of Telemedicine: Survey and Perspectives
文章

Ebook: The Rise of Telemedicine: Survey and Perspectives

Ebook, Telemedicine, Healthcare and Life Sciences
The Future of the ACA in a Post-Ginsburg World
文章

The Future of the ACA in a Post-Ginsburg World

Affordable Care Act, Supreme Court., U.S. Politics, Global Politics, Healthcare and Life Sciences
COVID-19 Vaccine Update: The Global Connection and Public Health Issues
文章

COVID-19 Vaccine Update: The Global Connection and Public Health Issues

Coronavirus, Vaccines, Healthcare and Life Sciences
COVID-19 Update: The Race for a Vaccine  
文章

COVID-19 Update: The Race for a Vaccine  

Coronavirus, Vaccines, Healthcare and Life Sciences
Is the Fertility Solutions Space Due for a Recovery Soon?
文章

Is the Fertility Solutions Space Due for a Recovery Soon?

Femtech, Technology, Healthcare and Life Sciences
Huge Growth Potential in Femtech and Maternal Services
文章

Huge Growth Potential in Femtech and Maternal Services

Femtech, Technology, Healthcare and Life Sciences
Telemedicine Survey: Patient and Physician Adoption
文章

Telemedicine Survey: Patient and Physician Adoption

Survey, Telemedicine, Healthcare and Life Sciences
Women Want Menopause Solutions. Will Companies Meet the Need?
文章

Women Want Menopause Solutions. Will Companies Meet the Need?

Femtech, Technology, Healthcare and Life Sciences
Telemedicine Dynamics: Regulatory Perspective
文章

Telemedicine Dynamics: Regulatory Perspective

Telemedicine, Healthcare and Life Sciences
What Does K-12 School Reopening Look Like for Students?
文章

What Does K-12 School Reopening Look Like for Students?

Coronavirus, Education Industry, K-12, New Normal, Healthcare and Life Sciences
Telemedicine Dynamics: Payer Perspective
文章

Telemedicine Dynamics: Payer Perspective

Payers, Telemedicine, Healthcare and Life Sciences
COVID-19 Vaccines: Moderna, Pfizer/BioNTech, AstraZeneca/Oxford
文章

COVID-19 Vaccines: Moderna, Pfizer/BioNTech, AstraZeneca/Oxford

Coronavirus, Vaccines, Healthcare and Life Sciences
A Look at Moderna’s SARS-CoV-2 Vaccine
文章

A Look at Moderna’s SARS-CoV-2 Vaccine

Coronavirus, Healthcare and Life Sciences
The Cast Is Coming Off for the Orthopedics Field to Make a Full Recovery
文章

The Cast Is Coming Off for the Orthopedics Field to Make a Full Recovery

Coronavirus, Healthcare and Life Sciences
Dermatology’s COVID-19 Problems Are Deep and Will Take Time to Heal
文章

Dermatology’s COVID-19 Problems Are Deep and Will Take Time to Heal

Coronavirus, Healthcare and Life Sciences
COVID-19 May Have Blurred the Ophthalmology Sector, but Recovery Is a Few Blinks Away
文章

COVID-19 May Have Blurred the Ophthalmology Sector, but Recovery Is a Few Blinks Away

Coronavirus, Healthcare and Life Sciences
COVID-19 and Public Perception
文章

COVID-19 and Public Perception

Coronavirus, Healthcare and Life Sciences
A Quick Take on STAT’s Remdesivir April 16 Reporting
文章

A Quick Take on STAT’s Remdesivir April 16 Reporting

Coronavirus, Healthcare and Life Sciences
How Prepared Are Hospitals for the Surge of COVID-19 Patients?
文章

How Prepared Are Hospitals for the Surge of COVID-19 Patients?

Coronavirus, Healthcare and Life Sciences
Shelter-in-Place May Not Be Enough to Fight COVID-19, Says Former CDC Doctor
文章

Shelter-in-Place May Not Be Enough to Fight COVID-19, Says Former CDC Doctor

Coronavirus, Healthcare and Life Sciences
Where We Are in the Global Response to COVID-19
文章

Where We Are in the Global Response to COVID-19

Coronavirus, Healthcare and Life Sciences
COVID-19: A Former City Health Commissioner’s Perspective
文章

COVID-19: A Former City Health Commissioner’s Perspective

Coronavirus, Healthcare and Life Sciences
What Will It Take to Develop a Vaccine for the Virus that Causes COVID-19?
文章

What Will It Take to Develop a Vaccine for the Virus that Causes COVID-19?

Coronavirus, Healthcare and Life Sciences
How Will COVID-19 Affect the Business of U.S. Hospitals?
文章

How Will COVID-19 Affect the Business of U.S. Hospitals?

Coronavirus, Healthcare and Life Sciences
COVID-19: What We Know So Far February 25
文章

COVID-19: What We Know So Far February 25

Coronavirus, Healthcare and Life Sciences
Assessing the COVID-19 Outbreak Jan 31
文章

Assessing the COVID-19 Outbreak Jan 31

Coronavirus, Healthcare and Life Sciences

订阅 GLG 洞见趋势月度专栏

输入您的电子邮件，接收我们的月度通讯，获取来自全球约 100 万名 GLG 专家团成员的专业洞见。